Clinical Trial Update: Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease [Phase 3]

View source ↗

Summary

This report indicates completion of a Phase 3 trial evaluating the efficacy and safety of ONCOXIN in patients with fibrocystic breast disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrocystic Breast Disease

Drugs mentioned

• ONCOXIN

Snippet

Sponsor: Catalysis SL | Conditions: Breast Fibrocystic Disease | Phase 3 | Status: COMPLETED